Pharsight

GENMAB AS PATENTS FACING OPPOSITIONS

Top patents of GENMAB AS facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3312196B1 17 Jul, 2019 Antibodies Against Cd38 For Treatment Of Multiple Myeloma Mar, 2026 1
EP2535355B1 02 Jan, 2019 Antibodies Against Cd38 For Treatment Of Multiple Myeloma Mar, 2026 1